|
|
||||||||





* Center for Pulmonary and Infectious Disease Control, Departments of
Microbiology and Immunology and
Biochemistry, University of Texas Health Center, Tyler, TX 75708;
Epimmune and
¶ La Jolla Institute for Allergy and Immunology, San Diego, CA 92121; and
|| National Cancer Institute, Bethesda, MD 20892
An intact T cell compartment and IFN-
signaling are required for protective immunity against Chlamydia. In the mouse model of Chlamydia pneumoniae (Cpn) infection, this immunity is critically dependent on CD8+ T cells. Recently we reported that Cpn-infected mice generate an MHC class I-restricted CD8+ Tc1 response against various Cpn Ags, and that CD8+ CTL to multiple epitopes inhibit Cpn growth in vitro. Here, we engineered a DNA minigene encoding seven H-2b-restricted Cpn CTL epitopes, the universal pan-DR epitope Th epitope, and an endoplasmic reticulum-translocating signal sequence. Immunization of C57BL/6 mice with this construct primed IFN-
-producing CD8+ CTL against all seven CTL epitopes. CD8+ T cell lines generated to minigene-encoded CTL epitopes secreted IFN-
and TNF-
and exhibited CTL activity upon recognition of Cpn-infected macrophages. Following intranasal challenge with Cpn, a 3.6 log reduction in mean lung bacterial numbers compared with control animals was obtained. Using a 20-fold increase in the Cpn challenging dose, minigene-vaccinated mice had a 60-fold reduction in lung bacterial loads, compared with controls. Immunization and challenge studies with
2-microglobulin/ mice indicated that the reduction of lung Cpn burdens was mediated by the MHC class I-dependent CD8+ T cells to minigene-included Cpn CTL epitopes, rather than by pan-DR epitope-specific CD4+ T cells. This constitutes the first demonstration of significant protection achieved by immunization with a CD8+ T cell epitope-based DNA construct in a bacterial system and provides the basis for the optimal design of multicomponent anti-Cpn vaccines for humans.
This article has been cited by other articles:
![]() |
C. Cortes, K. A. Rzomp, A. Tvinnereim, M. A. Scidmore, and B. Wizel Chlamydia pneumoniae Inclusion Membrane Protein Cpn0585 Interacts with Multiple Rab GTPases Infect. Immun., December 1, 2007; 75(12): 5586 - 5596. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tvinnereim and B. Wizel CD8+ T Cell Protective Immunity against Chlamydia pneumoniae Includes an H2-M3-Restricted Response That Is Largely CD4+ T Cell-Independent J. Immunol., September 15, 2007; 179(6): 3947 - 3957. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tian, A. Groner, M. Boes, and L.-a. Pirofski Pneumococcal Capsular Polysaccharide Vaccine-Mediated Protection against Serotype 3 Streptococcus pneumoniae in Immunodeficient Mice Infect. Immun., April 1, 2007; 75(4): 1643 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Joyee, H. Qiu, S. Wang, Y. Fan, L. Bilenki, and X. Yang Distinct NKT Cell Subsets Are Induced by Different Chlamydia Species Leading to Differential Adaptive Immunity and Host Resistance to the Infections J. Immunol., January 15, 2007; 178(2): 1048 - 1058. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |